Filya Zhebrovska, Chairman of the Supervisory Board of Farmak JSC, has joined the ranks of the rating of top managers in Ukraine carried out by Focus magazine. It's worth noting that two women are in this rating and she is one of them.
37 pharmaceutical companies from Ukraine, Moldova, the Republic of Lithuania, the Czech Republic, Israel, Armenia, the Kyrgyz Republic visited the production plants of Farmak JSC within the framework of the ISPE Conference "Countries of Eastern Europe" (ISPE – The International Society for Pharmaceutical Engineering).
June 2 is the date on which the final of the Eco-School project will be held, as implemented by Farmak JSC in conjunction with the All-Ukrainian Youth Movement Let's do it, Ukraine.
Farmak JSC, as part of the Consortium of Scientific Institutions and Industrial Partners from the EU and the USA, started implementing the ORBIS project within the framework of the European Commission's Scientific Grants Program Horizon-2020.
The essence of the project is exchange of scientific experience and innovations in order to improve and accelerate the development and research of medicinal products at an early stage with a special focus on processes and technology.
Farmak JSC increased its medicine sales by 18.35%
Farmak JSC resumed production of the drug L-Thyroxine-Farmak 100 mcg tablets No.50 from April 2018.
• Farmak JSC is going to invest 638 million UAH this year on modernization of production. This is 32% more than in 2017.
The sales of Farmak pharmaceutical company increased by 19% in 2017, net profit by 22%. The company launched 21 new products onto the market.
Environmental protection is one of the priorities of Farmak JSC. The company systematically implements projects aimed at improving the ecological state of the country.